“This is the first step,” said Dr. Robert Vonderheide, president-elect of the American Association for Cancer Research and ...
The field has been looking for a win and I think this one is a big one,” said Dr. Hussein Tawbi of MD Anderson Cancer Center ...
A bespoke vaccine that is tailored to target an individual's unique skin cancer reduced rates of recurrence or death in a ...
Biotech company Moderna ($MRNA) saw its shares fall by as much as 25% on Thursday, October 22, despite positive results from ...
The data were not bad — in fact, the outcome was better than many analysts had predicted. The problem was Cambridge-based ...
When COVID-19 vaccines first rolled out, pregnant women were largely left out of the original clinical trials, leaving them ...